Sangamo Therapeutics SGMO Stock Momentum Analysis Sangamo Therapeutics posts 797 downside EPS miss CINF Cincy Fin posts 143 percent Q4 2025 EPS beat yet shares slide 22 percent in todays trading session Southern Company SO Mixed Analyst Price Target Adjustments Amid Utility Sector Outperformance